Recurrent Clostridioides difficile infection: Recognition, management, prevention

被引:18
|
作者
Tsigrelis, Constantine [1 ,2 ]
机构
[1] Cleveland Clin, Dept Infect Dis, G21,9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA
关键词
FECAL MICROBIOTA TRANSPLANTATION; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INTESTINAL MICROBIOME; DISEASES SOCIETY; VANCOMYCIN; BEZLOTOXUMAB; UPDATE; ADULTS; FIDAXOMICIN;
D O I
10.3949/ccjm.87gr.20001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridioides difficile infection (CDI) is the most common cause of diarrhea in hospitalized patients and results in substantial morbidity, mortality, and costs. Its clinical management, primarily with antibiotics, is often complicated by recurrent episodes. These recurrent CDI episodes are thought to be caused by antibiotic disruption of colonic microbiota and usually occur within 4 weeks of completing antibiotic therapy. The risk of recurrent CDI increases after the first episode, creating a need for management strategies to diagnose, treat, and prevent these complications.
引用
收藏
页码:347 / 359
页数:13
相关论文
共 50 条
  • [1] Emerging Options for the Prevention and Management of Clostridioides difficile Infection
    Gonzales-Luna, Anne J. J.
    Carlson, Travis J. J.
    Garey, Kevin W. W.
    DRUGS, 2023, 83 (02) : 105 - 116
  • [2] Management of Clostridioides difficile Infection
    Clarkin, Christina
    Quist, Stephanie
    Shamis, Renata
    King, Amber E.
    Shah, Bhavik M.
    CRITICAL CARE NURSE, 2019, 39 (05) : E1 - E12
  • [3] Clostridioides difficile Infection: Update on Management
    Mounsey, Anne
    Smith, Kelly Lacy
    Reddy, Vinay C.
    Nickolich, Sarah
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (03) : 168 - 175
  • [4] Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection
    Berry, Parul
    Khanna, Sahil
    FUTURE MICROBIOLOGY, 2024, 19 (18) : 1519 - 1528
  • [5] Recent developments in the management of recurrent Clostridioides difficile infection
    Mendo-Lopez, Rafael
    Villafuerte-Galvez, Javier
    White, Nicole
    Mahoney, Monica, V
    Kelly, Ciaran P.
    Alonso, Carolyn D.
    ANAEROBE, 2020, 62
  • [6] Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review
    Bainum, Taryn B.
    Reveles, Kelly R.
    Hall, Ronald G.
    Cornell, Kelli
    Alvarez, Carlos A.
    MICROORGANISMS, 2023, 11 (02)
  • [7] Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection
    Feuerstadt, Paul
    Allegretti, Jessica R.
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (08) : 1303 - 1306
  • [8] Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials
    Madoff, Sarah E.
    Urquiaga, Mariana
    Alonso, Carolyn D.
    Kelly, Ciaran P.
    ANAEROBE, 2020, 61
  • [9] Management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Khanna, Sahil
    INTESTINAL RESEARCH, 2021, 19 (03) : 265 - 274
  • [10] Management and Outcomes of Patients at a Specialty Clinic for Clostridioides difficile Infection
    Hunt, Aaron
    Danziger, Larry H.
    Johnson, Stuart
    Skinner, Andrew M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):